Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Translational Extracellular Matrix Spray-Coating Approach for Large-Scale Bioactive Surface Functionalization and Tissue Repair

Brilian AI., Lim C., Lee G., Lee SH., Mahardika IH., Yoo SH.

Animal Study on Chronic Wound, published in Adv Healthc Mater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Adv Healthc Mater (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40787727
PMCID
PMC12645076
DOI
10.1002/adhm.202502804
Citations
2

Abstract (original English)

While various extracellular matrix (ECM)-based delivery platforms such as cell sheets, nanoparticles, and dressings have demonstrated potential for tissue repair, their clinical translation remains limited by poor scalability, structural fragility, and substrate-specific constraints. This study introduces a translational spray-coating strategy capable of conformationally activating ECM proteins, specifically fibronectin (FN) and collagen (COL), via mechanical unfolding during deposition. Using a commercially available airbrush, micrometer-scale droplets are uniformly deposited onto diverse biomedical substrates, including polydioxanone sutures and oxidized regenerated cellulose/collagen dressings, without structural damage. Notably, FN undergoes conformational changes that enhance cell adhesion, while multi-ECM sprays promote fibrillogenesis, directional matrix organization, and increase fibroblast migration and proliferation. In a full-thickness murine wound model, sequential ECM spraying results in a 88.2% wound closure rate and 66.6% COL density, outperforming both drop-treated and commercial control groups. These findings position ECM spray-coating as a scalable, bioactive platform for advanced wound therapy and surface functionalization in regenerative medicine.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Extracellular MatrixFibroblastsAnimalsHumansMiceCollagenFibronectinsCoated Materials, BiocompatibleWound HealingCell Adhesion

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research